Transcript Diapositive 1 - Rob Stansfield

Retrospective
The Cross Pharma HPC Forum
(almost) four years on…
Rob Stansfield
October 13, 2011
1
Quantitative & Qualitative
●
(almost) 4 years
●
● Since December 12, 2007
●
6 companies + Intel at the start
● BMS, GSK, J&J, Merck, Pfizer,
Wyeth + Intel
●
●
Gene Fluder (Merck)
● 2009
●
Up to ~30 attendees at a meeting
John Morris (Wyeth >> Pfizer)
● 2010
Up to ~16 companies represented
● Abbott Labs, Astra Zeneca,
Biogen Idec, BMS, BoehringerIngelheim, Congenomics, Eli
Lilly, GSK, J&J, Merck, Novartis,
Pfizer, Roche, Sanofi-aventis,
Schering-Plough, Wyeth + Intel
●
● 2008
16 face to face meetings
● Quarterly
●
Dave Torgersen (Pfizer)
●
Zheng Yang (GSK  BI)
● 2011
●
Rob Stansfield (Sanofi)
● 2012
RETROSPECTIVE – The Cross Pharma HPC Forum
| 2
SPECTRE
SPEcific Computing for Tomorrow’s Research Environment
● Zheng Yang
(Dr. No) Dr. No
●
Gene Fluder
(Blofeld) Diamonds Are Forever
●
Jeff Mathers
(Goldfinger) Goldfinger
●
Tim Wagner
(Scaramanga) Man With the Golden Gun
●
John Morris
(Le Chiffre) Casino Royale
●
Dave Torgersen (Max Zorin) A View To A Kill
●
Mike Shevlin
(Nick Nack) Man With the Golden Gun
RETROSPECTIVE – The Cross Pharma HPC Forum
| 3
F2F Meetings Attendance
Cross Pharma HPC Forum - 2008 to 2010
Number of representatives
35
30
25
20
Attendees
Companies
15
10
5
0
Kickoff
1Q 08
2Q 08
3Q 08
4Q 08
1Q 09
2Q 09
3Q 09
4Q 09
Date of F2F quarterly meeting
Propose 1.5 days meeting
1Q 10
2Q 10
3Q 10
4Q 10
Oct ’09 : Merck  Schering Plough
Nov ’09 : Pfizer  Wyeth
RETROSPECTIVE – The Cross Pharma HPC Forum
| 4
Themes
●
Early proposals
●
●
●
●
●
Early 2008
●
Standardization
Software license models
API standards
Non-proprietary code
exchanges
●
●
●
●
Member companies
●
●
Presentations
HPC Overview
●
●
Forum charter and mission, Voting rights,
Visibility, Publish an article?
Governance, Role of Central IT
Growth of Linux, Grid computing
(Univa/UD), Computing on demand
Storage, Collaborative (Open Source)
software development
Vendor management,
License management  ROI analyses
Late 2008
●
●
●
●
Clear and attainable goals for Forum
Invite ISV’s vs. do not invite ISV’s
New technologies, Cloud Computing
Doing science better  Doing better science
RETROSPECTIVE – The Cross Pharma HPC Forum
| 5
Themes (continued)
●
Early 2009
●
● Best practices, Conference reports
● NONMEM rewrite?, GPU
● Storage / Specialized storage
●
●
●
●
●
Late 2009
●
●
●
●
●
●
Introspection – User Group?
Special Interest? Task Force?
Emerging technologies (and ICAP
companies), HPC benchmarking
File systems (e.g. pNFS vs. PVFS)
Emerging Science (enabled by HPC)
Sub groups / Tech committee on
advanced topics, working via
teleconference
GUI for Molecular Dynamics, CCG
(MOE)
Early 2010
●
Big data (Broad Institute)
HPC at Intel
Cray Computer
Workflow tools (Pipeline Pilot,
Knime, et al)
Late 2010
●
●
Next-gen sequencing
NVIDIA (GPU, CUDA, NONMEM)
RETROSPECTIVE – The Cross Pharma HPC Forum
| 6
Six Illustrative Themes
2007
0
2008
1
2
3
2009
4
5
6
7
2010
8
9
10
11
2011
12
13
14
15
MISSION / CHARTER
VENDOR MANAGEMENT
SOFTWARE LICENSING
CLOUD COMPUTING
BEST PRACTICES
MARKETING
RETROSPECTIVE – The Cross Pharma HPC Forum
| 7
Mission / Charter
2007
0
2008
1
2
3
2009
4
5
6
7
2010
8
9
10
11
2011
12
13
14
15
MISSION / CHARTER
To (accelerate) improve
pharmaceutical research
and scientific outcomes
by collaborating to
optimize HPC capabilities,
promote standards, and
develop best practices
Group goals
and purpose
redux
Action
to draft
charter
Final
version
agreed
“Get my stuff done and make sure my
manager can get to it and if there are
mistakes re-run the job and also make sure it
integrates with the tools I am using today”
Jeff Mathers, J&J, Meeting #1, 30-Jan-08
“To improve the level of
support and responsiveness
to the scientific community”
Executive Summary, Meeting #0
Ref: Pistoia Alliance
presentation
RETROSPECTIVE – The Cross Pharma HPC Forum
| 8
Charter
Mission
The mission of the Cross-Pharma HPC Forum is to improve the outcomes
of scientific research, in time, quality, and cost, by maximizing the value of
HPC in pharmaceutical R&D through collaboration to optimize capabilities,
to promote standards, and to develop best practices
The major goals of the Cross-Pharma HPC Forum are to:
●
Goals
●
●
●
●
●
Establish and maintain a network among the member companies that
fosters open communication of non-commercially sensitive information;
Educate members regarding best practices in the exploitation and
management of HPC in the pharmaceutical and other industries;
Promote the development and use of open standards for specialized
scientific applications in pharmaceutical R&D;
Identify challenges, scientific and otherwise, where the collective influence
and pooled efforts of the members can be leveraged for mutual benefit;
Create opportunities for open and informal dialogue between the members
and suppliers of HPC products and services;
Alert members to new and emerging information technologies and products
of special relevance to HPC in pharmaceutical R&D and to coordinate efforts
accordingly.
RETROSPECTIVE – The Cross Pharma HPC Forum
| 9
Vendor Management / OS Framework
2007
0
2008
1
2
2009
3
Ref: Peter Krey
JPMorganChase
4
5
6
7
2010
8
9
Ref: BioConductor “R” presentation
Ref: Open Source SB-Grid presentation
VENDOR MANAGEMENT
Proposal for Open
Source initiative to
develop a framework to optimize
(counter / enhance)
vendor solutions
Top 10 vendors
Top 5 vendors
Intel ISV
engagement
model
10
11
2011
12
13
14
15
Advice from Wall Street
“Step on the air hose – when they
can’t breathe, then they’ll listen”
Peter Krey, JPMorganChase, Meeting #3
Group agrees to
not to pursue
further
-Schrodinger
-Accelrys
-Mathworks
-Ariadne
-Ingenuity
Working Group focus on Chemistry
Reference: Collaborative Software Initiative (CSI) for OS development
Reference: ACORD strategy (standards-setting for insurance industry)
RETROSPECTIVE – The Cross Pharma HPC Forum
| 10
Software Licensing
2007
0
2008
1
2
Pfizer’s
“S” curve
Several companies
experiencing
challenges in
negotiating licenses
3
2009
4
HPC SW
Licensing
Scorecard
5
7
Discussion
ends
naturally
8
9
10
11
2011
12
13
14
15
Revisited
SOFTWARE LICENSING
Outline for Top 10 vendors
a licensing Top 5 vendors
position
-Schrodinger
paper
Working Group
6
2010
Intel ISV
engagement
model
-Accelrys
-Mathworks
-Ariadne
-Ingenuity
RETROSPECTIVE – The Cross Pharma HPC Forum
| 11
Vendor Management & Software Licensing
●
Valuable documents
● Licensing position paper from 2008
● HPC SW Licensing scorecard from 2008
●
Valuable reference models
● “S” curve – as a model of desirable software licensing
● ACORD – as a model of standards setting
● BioConductor, Open-SB, CSI – as models of collaborative and Open
Source software development
● Wall street – as a model for vendor management
●
Vendor identification
● And identification of alternatives
●
Intel as facilitator
RETROSPECTIVE – The Cross Pharma HPC Forum
| 12
Cloud Computing
2007
0
2008
1
2
3
2009
4
5
6
7
2010
8
9
10
2011
11
12
13
BioIT World
EMC on
Cloud
storage
Moderated
discussion
 5 “pilots”
GSK (UK) on
the economics of
Cloud Computing
14
15
BioIT World
Co-meeting with
Sanofi-aventis &
Sanofi Pasteur
CLOUD COMPUTING
Lilly Cloud 1.0
live demo using
AWS for IaaS
Lilly update
Pfizer update
Chris Dag
(BioTeam)
Everyone is
in this game !!
(see next slide)
RETROSPECTIVE – The Cross Pharma HPC Forum
| 13
Meeting #14, 2Q (Jun 22-23), 2011
●
Every Pharma company represented is either already using AWS or
starting evaluations and pilots
● Pfizer use AWS for production scientific HPC with a "DIY" approach to
building and automating the service
● Merck will copy Pfizer
● Eli Lilly have worked with Cycle Computing as an intermediary to AWS for
three years
● JnJ already use AWS for some other purposes (e.g. TranSMART), and are
starting an evaluation with Cycle Computing
● Boehringer Ingelheim and Roche expressed their intent to start evaluating
public cloud this year
● Novartis (NIBR) have been working with CloudSwitch for secure hybrid
cloud since one year
• Conclusion - good for external application hosting, not good for HPC
● and have evaluated several sources for external scientific HPC, including
Dell and Cycle Computing
RETROSPECTIVE – The Cross Pharma HPC Forum
| 14
Best Practices
2007
0
2008
1
2
3
2009
4
5
6
7
2010
8
9
10
11
2011
12
13
14
15
Report on PRIME
meeting of Apr 30
Proposal from
Tabor Research
Survey definition
7 companies commit
BEST PRACTICES
Tabor  InterSect 360
Final report
RETROSPECTIVE – The Cross Pharma HPC Forum
| 15
Best Practices
●
Final report
● Seven participating (paying) companies
● Very diverse approaches in each organization
• Different users distributions
• Different organizations
• Different architectures
●
Expected
● Common issues, challenges, to which organizations adapt
●
Unexpected
● No single Best Practice identified
●
A successful collaboration on a jointly financed exercise
● Motivated by self-interest in anonymized benchmarking
RETROSPECTIVE – The Cross Pharma HPC Forum
| 16
Marketing
2007
0
2008
1
2
3
2009
4
5
6
7
2010
8
Plan for ACS Fall
presentations
Yahoo  Website
9
10
11
2011
12
13
14
15
Four public presentations
at the ACS Fall annual
meeting
MARKETING
RETROSPECTIVE – The Cross Pharma HPC Forum
| 17
Personal (Sanofi) Highlights
●
Pat Gelsinger (Intel)
● April 2008, e.g. future of Infiniband vs. 10Gb Ethernet
●
Between meetings (2Q 2008)
● Clustered storage discussion facilitated by G.Pocina (Pfizer)
● Experiences of Michael Parker and John Dey at Merck (Rosetta)
with multiple storage solutions, as well as Pfizer
● Pointed us to Isilon systems
• Evaluation  Benchmarking  Purchase
●
Peter Krey (JPMorganChase)
● July 2008, Tough approach to vendor management
●
Dave Powers, Andrew Kaczorak (Eli Lilly)
● Sep 2008, Cloud Computing live demo
RETROSPECTIVE – The Cross Pharma HPC Forum
| 18
Thank You!
19
Quarterly Meetings
Date
Location
Attendees
Companies
Agenda & Presentations
20
Meeting #0
●
The Kickoff !
● December 12, 2007
● Mediterra Restaurant,
Princeton, NJ
●
●
●
“Pharma IT Forum”
Attendees (~10)
Companies (7)
●
●
Agenda & Presentations
●
●
BMS, GSK, Intel, J&J, Merck, Pfizer,
Wyeth
●
●
Discussion around forming the
group
• Organizational situation
• Principles for the “forum”
• Ongoing challenges
Branding
• SPECTRE = SPEcific Computing
for Tomorrow’s Research
Environment
HPC in Pfizer
• Dave Torgersen
Linux and HPC
• John Morris, Wyeth Research
RETROSPECTIVE – The Cross Pharma HPC Forum
| 21
Meeting #1
●
●
1Q 2008
Agenda & Presentations
● January 30, 2008
● J&J R&D, Raritan, NJ
●
“Pharma IT Forum”
Mission Statement (WIP)
●
●
●
●
●
“To (accelerate) improve
pharmaceutical research and
scientific outcomes by collaborating
to optimize HPC capabilities,
promote standards, and develop best
practices.”
Attendees (~11)
Companies (7)
●
BMS, GSK, Intel, J&J, Merck, Pfizer,
+Wyeth
●
●
●
●
Pfizer company presentation
• Dave Torgersen
Merck company presentation
• Gene Fluder
J&J company presentation
• Jeff Mathers
Wyeth Research presentation
• John Morris
GSK company presentation
• Zheng Yang
BMS company presentation
• Tim Wagner
RETROSPECTIVE – The Cross Pharma HPC Forum
| 22
Meeting #2
●
2Q 2008
●
● April 29, 2008
● Intel, Cambridge, MA
●
●
●
“Cross Pharma HPC Consortium”
Attendees (~20)
Companies (10)
●
+Astra Zeneca, BMS, GSK, Intel, J&J,
Merck, Novartis, Pfizer, +Sanofiaventis, Wyeth
Preceding evening
●
●
Dinner with Pat Gelsinger, SVP and
General Manager of Intel’s Digital
Enterprise Group
Agenda & Presentations
●
●
●
●
●
Sanofi-aventis presentation
• Rob Stansfield
Novartis company presentation
• Jason Calvert
Vendor Management & Licensing
• Mike Miller, Pfizer
Licensing discussion
Application Deployment best
practices in Scientific Computing
• Tim Wagner, BMS
• Intel CTO
RETROSPECTIVE – The Cross Pharma HPC Forum
| 23
Meeting #3
●
3Q 2008
●
● July 15, 2008
● GSK, Collegeville, PA
●
●
●
“Cross Pharma HPC Forum”
Attendees (~20)
Companies (9)
●
BMS, GSK, Intel, J&J, Merck,
Novartis, Pfizer, Sanofi-aventis,
Wyeth
Preceding evening
●
●
Hosted dinner courtesy IBM
• Steven Simon, Director of IBM’s
System and Technology Group
Industry Solution Centers
• Peter Krey, Wall Street Executive
Agenda & Presentations
●
●
●
●
Licensing Working Group
• Draft position paper
Discussion over working lunch
Presentation on Wall Street
experience with vendor management
• Peter Krey, Krey Associates, Head
of Research & Engineering, IB
Architecture, JPMorganChase
Open Source Working Group
• Status and next steps
RETROSPECTIVE – The Cross Pharma HPC Forum
| 24
Meeting #4
●
4Q 2008
● September 23, 2008
● Merck, Rahway, NJ
●
●
Attendees (~27)
Companies (11)
●
BMS, +Eli Lilly, GSK, Intel, J&J,
Merck, Novartis, Pfizer, Sanofiaventis, +Schering-Plough, Wyeth
●
Agenda & Presentations
●
●
●
●
●
●
Preceding evening
● Dinner courtesy of IBM
● Michael Hehenberger, IBM Global
Life Science R&D Solutions
●
●
Schering Plough presentation
• Corey Strickland
Eli Lilly company presentation
• Andrew Kaczorek
Licensing Position Paper
• Goran Pocina (Pfizer)
Forum goals and purpose redux
• John Morris (Wyeth)
Vendor Management
• Top ten ranked in order
• Top five ranked by votes
•  SW Licensing Scorecard
Cloud Computing
• Dave Powers (Eli Lilly)
Open Source project
• Mike Miller (Pfizer)
RETROSPECTIVE – The Cross Pharma HPC Forum
| 25
Meeting #5
●
1Q 2009
● January 14, 2009
● Novartis (NIBR), Cambridge, MA
●
●
Attendees (~33)
Companies (15)
●
●
Preceding Evening
●
●
+Abbott Labs, BMS, +BoehringerIngelheim, +Congenomics, +Harvard
Med School, Eli Lilly, GSK, Intel, J&J,
Merck, Novartis, Pfizer, Sanofiaventis, Schering-Plough, Wyeth
Dinner courtesy of EMC
Agenda & Presentations
●
BI company presentation
• Miguel Teodoro
●
(cont.)
●
●
●
●
●
●
●
Abbott Labs presentation
• Scott Brown, Steve Muchmore
BioConductor project
• Vincent Cary,
Harvard Medical School
Open Source SB-Grid
• Piotr Sliz, Harvard Medical School
SuperComputing 08 recap
• J.Morris (Wyeth), A.Kaczorak
(Lilly), G.Stiegler (BMS), G.Pocina
(Pfizer)
Best Practices proposal w Tabor
• John Morris (Wyeth)
Pistoia Alliance
• Debbie Igo (Novartis)
ISV Engagement Model
• Henry Gabb (Intel)
RETROSPECTIVE – The Cross Pharma HPC Forum
| 26
Meeting #6
●
●
2Q 2009
● May 5-6, 2009
● Sanofi-aventis, Bridgewater, NJ
●
●
Attendees (~20)
Companies (11)
●
BMS, BI, Congenomics, GSK, Intel,
J&J, Merck, Pfizer, Sanofi-aventis,
Schering-Plough, Wyeth
●
●
●
Dinner
Day 2 : Agenda & Presentations
●
●
●
Day 1 : Agenda & Presentations
●
Best Practices survey
• John Morris (Wyeth)
• Invite 13 companies
Review of PRIME meeting on April 30
in Groton (Pfizer)
Vendor interaction
• Mike Miller (Pfizer)
●
●
Formal charter discussion
• Gene Fluder (Merck)
HPC Storage
• John Morris (Wyeth),
Rich Bach (Merck)
Future Topics
• Gene Fluder (Merck)
Cloud Computing
• M.Teodoro (BI),
S.Piotrowski (J&J)
•  Five companies pursuing
RETROSPECTIVE – The Cross Pharma HPC Forum
| 27
Meeting #7
●
3Q 2009
● August 10-11, 2009
● BMS, Pennington, NJ
●
●
Attendees (~21)
Companies (14)
●
●
Abbott Labs, BMS, BI, Congenomics,
Eli Lilly, GSK, Intel, J&J, Merck,
Novartis, Pfizer, Sanofi-aventis,
Schering-Plough, Wyeth
●
Dinner
●
●
Day 2 : Agenda & Presentations
●
●
●
●
Day 1 : Agenda & Presentations
●
Intel Capital’s Investment portfolio,
emerging technologies
• Six company presentations
Hosted by Intel
●
Vendor interaction update
• Mike Miller (Pfizer)
Best Practices survey update
• John Morris (Wyeth)
HPC enablement for Molecular
Dynamics
• Zheng Yang (GSK)
Forum objective and strategy
• Gene Fluder (Merck)
pNFS vs. PVFS
• Rich Bach (Merck)
RETROSPECTIVE – The Cross Pharma HPC Forum
| 28
Meeting #8
●
4Q 2009 (RS not present)
● October 22-23, 2009
● Pfizer, Groton, CT
●
●
Attendees (~?)
Companies (?)
●
Day 1 : Agenda & Presentations
●
●
●
Review/Acceptance of Mission
Statement
• John Morris (Wyeth)
GUI discussion
• Miguel Teodoro (BI)
Best Practices survey update
• Addison Snell (Tabor),
John Morris (Wyeth)
●
Dinner
●
●
Hosted by Isilon
Day 2 : Agenda & Presentations
●
●
●
●
●
Marketing and publicity
• Gene Fluder (Merck),
Zheng Yang (GSK)
Current efforts / update
• Gene Fluder (Merck)
Current efforts / update
• Mike Miller (Pfizer)
Technology roundtable
• Greg Stiegler (BMS),
Corey Strickland (S-P)
Industry Trends
• Chris Dwan (BioTeam)
RETROSPECTIVE – The Cross Pharma HPC Forum
| 29
Mergers & Acquisitions
Oct 2009 : Pfizer  Wyeth
Nov 2009 : Merck  Schering-Plough
30
Meeting #9
●
1Q 2010
●
●
●
●
Attendees (~19)
Companies (10)
●
●
March 1-2, 2010
B-I, Ridgefield, CT
BMS, BI, Congenomics, Eli Lilly,
GSK, Intel, J&J, Merck, Pfizer,
Sanofi-aventis, [Wyeth]
Day 1 : Agenda & Presentations
●
●
●
MOE / NAMD GUI dev. Update
• Paul Labute (CCG Inc.)
Broad Institute infrastructure
• Matt Trunnell
HPC at Intel
• Shesha Krishnapura
(a talk delivered at SC ’09)
●
Dinner
●
●
Hosted by Intel
Day 2 : Agenda & Presentations
●
●
●
●
●
●
HPC Grid at GSK
• Jeremy Martin
Workflow tools update
• Steve Litster
HPC at Sanofi-aventis
• Rob Stansfield
Marketing/Publicity & ACS
• Z.Yang (GSK), G.Fluder (Merck),
R.Bruccoleri Congenomics),
M.Miller (Pfizer
•  Fall ACS National Meeting
Cloud Computing
• G.Stiegler (BMS), D.Powers (Lilly),
M.Miller (Pfizer)
Best Practices Report
• Addison Snell (InterSect 360)
RETROSPECTIVE – The Cross Pharma HPC Forum
| 31
Meeting #10
●
●
2Q 2010
● May 13-14, 2010
● Merck (ex S-P), Kenilworth, NJ
●
●
Attendees (~24)
Companies (10)
●
●
BMS, BI, Congenomics, GSK, Intel,
J&J, Merck, Novartis, Pfizer, Sanofiaventis
●
●
Dinner
●
●
●
Day 1 : Agenda & Presentations
●
2010 BioIT World Summary
• R.Stansfield (Sanofi-aventis),
G.Stiegler (BMS), J.Morris (Pfizer)
ACS Conference preparations
• Z.Yang (GSK)
Hosted by Cray Computer
Day 2 : Agenda & Presentations
●
●
Cross Pharma HPC website
• R.Bruccoleri (Congenomics)
Cray Computer
• Barry Bolding
●
●
●
Workflow tools
• Steve Litster (Novartis)
Funding of projects
• Gene Fluder
HPC at Merck
• Gene Fluder
Cloud Technologies
• Chris Dagdigian (BioTeam)
Advanced Linux topics
• Greg Stiegler (BMS)
RETROSPECTIVE – The Cross Pharma HPC Forum
| 32
Meeting #11
●
●
●
3Q 2010 (plus ACS)
● ½ day, August 24, 2010
● Novartis (NIBR), Cambridge, MA
Attendees (~?)
Companies (?)
●
BMS, BI, Congenomics, GSK, Intel,
J&J, Merck, Novartis, Pfizer, Sanofiaventis
●
●
(cont.)
● Current Trends of HPC in Pharma
• Steve Litster (Novartis)
● Challenges & Collaboration...
• Rob Stansfield (Sanofi-aventis)
Dinner
●
Agenda & Presentations
●
●
●
ACS Fall Annual Meeting
●
●
August 25, 2010
Boston, MA
ACS Agenda
● Intro to X-Pharma HPC Forum
• John Morris (Pfizer)
● Applications & Use of Cloud…
• Mike Miller (Pfizer)
Hosted by VMWare
●
●
●
●
Website update
• R.Bruccoleri (Congenomics)
GSK HPC update
Workflow (Knime) update
• Steve Litster (NIBR)
Advanced Linux topics
• G.Stiegler (BMS)
VMWare presentation
RETROSPECTIVE – The Cross Pharma HPC Forum
| 33
Meeting #12
●
4Q 2010 (RS not present)
● November 11-12, 2010
● J&J, Spring House, PA
●
●
Attendees (~16)
Companies (8)
●
●
BMS, BI, Congenomics, GSK, Intel,
J&J, Merck, Pfizer
●
Dinner
• Hosted by SGI?
●
Day 2 : Agenda & Presentations
●
●
●
Day 1 : Agenda & Presentations
●
●
●
Advanced Linux Topics
• Greg Stiegler (BMS)
Protein Database System
• Corey Strickland (Merck) Proasis,
Marti Head (GSK) PSILO
Brainstorm on collaboration topics
• G.Fluder (Merck), Z.Yang (BI)
•  NONMEM optimization
●
●
Website update & LinkedIn
• R.Bruccoleri, Z.Yang (BI)
Intel many-core strategy
• Mike Shevlin
Cray feedback
• Gene Fluder (Merck)
HPC at J&J and Cloud Computing
• Zhen Min, Sebastian Piotrowski
New topics
RETROSPECTIVE – The Cross Pharma HPC Forum
| 34
Meeting #13
●
1Q 2011
●
● March 3-4, 2011
● Sanofi-aventis, Bridgewater, NJ
●
●
Attendees (~)
Companies ()
Day 1 : Agenda & Presentations
●
●
●
Dinner
●
●
Co-meeting with Sanofi-aventis and
Sanofi Pasteur
NVIDIA presentation
• Kimberly Powell et al
Hosted by NVIDIA
Day 2 : Agenda & Presentations
●
●
●
●
Eli Lilly company presentation
• Jon Klinginsmith
Workflow update
• Steve Litster (Novartis)
Intel-Oracle presentation
Discussion over ECLC
RETROSPECTIVE – The Cross Pharma HPC Forum
| 35
Meeting #14
●
2Q 2011
● June 22-23
● BMS, Lawrenceville, NJ
●
●
Attendees (~)
Companies ()
●
Dinner
●
●
Day 2 : Agenda & Presentations
●
●
●
Day 1 : Agenda & Presentations
●
●
●
●
Large scale data movement
• Mike Miller (Pfizer)
License practice discussion
• Stewart Samuel
Next generation sequencing
• Bob Bruccoleri (Congenomics)
IBM presentation
Hosted by IBM
●
●
●
●
Network connection discussion
• Steve Litster
Roche company presentation
• Michael Braxenthaler
Membership discussion
HP tech briefing
Follow-up discussion of GPGPU with
NVIDIA
• Gene Fluder (Merck)
Preparation for Q3 meeting
RETROSPECTIVE – The Cross Pharma HPC Forum
| 36